Relief of Chronic Neuropathic Pain through Endothelin Antagonism
No abstract is available. To read the body of this article, please view the Full Text online.
aThe Mater Misericordiae University Hospital, Dublin, Ireland
bDepartment of Respiratory Medicine, Cork University Hospital, Wilton, Cork, Ireland
Requests for reprints should be addressed to Sean Gaine, PhD, FRCPI, The National Pulmonary Hypertension Unit, The Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
Funding: SP Gaine has received speaking honoraria and attended advisory board meetings of many of the pharmaceutical companies involved in pulmonary arterial hypertension in the past year, including Actelion, Pfizer, Lung Rx, and GSK. He has no investment or stock interest in any pharmaceutical company. DM Murphy and DS O'Callaghan previously have received funding as recipients of European Respiratory Society Fellowships.
Conflict of Interest: None of the authors believe that they have any potential conflict of interest with the material presented in this manuscript.
Authorship: All authors had full access to the data necessary for the preparation of this article and were involved in manuscript preparation.
